18 May 2012
Interviewee/Contributer: Jane Buus Laursen
Organisation: AstraZeneca
Full text available to subscribers only. Click here for information on subscribing to MedNous.
Interviewee/Contributer: Rudy Dekeyser
Organisation: Flanders Institute for Biotechnology (VIB).
Interviewee/Contributer: Ulrich Mahr
Organisation: Max-Planck- Innovation GmbH
Interviewee/Contributer: Alan Aubrey
Organisation: IP Group
Interviewee/Contributer: Lita Nelsen
Organisation: MIT Technology Licensing Office
Interviewee/Contributer: Keith Blundy
Organisation: Cancer Research Technology
Wednesday May 16 2012
Saturday May 12 2012